Sampre Nutritions Ltd
Incorporated in 1991, Sampre Nutrition Ltd manufactures complete range of sugar confectionery, éclairs, candies, toffees, powder and center filled products.
- Market Cap ₹ 104 Cr.
- Current Price ₹ 11.0
- High / Low ₹ 42.3 / 5.76
- Stock P/E 33.8
- Book Value ₹ 11.3
- Dividend Yield 0.00 %
- ROCE 2.69 %
- ROE 3.11 %
- Face Value ₹ 5.00
Pros
- Stock is trading at 0.97 times its book value
- Company is expected to give good quarter
Cons
- Promoter holding has decreased over last quarter: -1.22%
- Promoter holding is low: 14.0%
- Company has a low return on equity of -2.45% over last 3 years.
- Working capital days have increased from 50.4 days to 71.6 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 37.11 | 25.15 | 25.12 | 43.35 | |
| 33.05 | 21.03 | 28.97 | 38.59 | |
| Operating Profit | 4.06 | 4.12 | -3.85 | 4.76 |
| OPM % | 10.94% | 16.38% | -15.33% | 10.98% |
| 0.07 | 0.12 | 0.37 | 0.43 | |
| Interest | 1.89 | 1.92 | 2.07 | 1.37 |
| Depreciation | 1.82 | 1.83 | 1.97 | 2.05 |
| Profit before tax | 0.42 | 0.49 | -7.52 | 1.77 |
| Tax % | 16.67% | 53.06% | 1.99% | -73.45% |
| 0.35 | 0.23 | -7.67 | 3.08 | |
| EPS in Rs | 0.13 | 0.08 | -0.91 | 0.32 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 5% |
| TTM: | 73% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 106% |
| TTM: | 140% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 19% |
| 3 Years: | -14% |
| 1 Year: | 81% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -2% |
| Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 6.87 | 7.27 | 21.01 | 47.50 |
| Reserves | 14.29 | 15.20 | 69.87 | 59.85 |
| 16.77 | 17.50 | 16.90 | 17.91 | |
| 5.66 | 4.78 | 7.65 | 9.12 | |
| Total Liabilities | 43.59 | 44.75 | 115.43 | 134.38 |
| 20.52 | 21.06 | 19.86 | 20.09 | |
| CWIP | 4.16 | 5.50 | 5.01 | 5.01 |
| Investments | 0.01 | 0.01 | 73.51 | 83.47 |
| 18.90 | 18.18 | 17.05 | 25.81 | |
| Total Assets | 43.59 | 44.75 | 115.43 | 134.38 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 0.88 | 3.95 | 0.08 | -1.10 | |
| -4.32 | -3.70 | -75.17 | -2.75 | |
| 3.48 | -0.09 | 75.03 | 3.70 | |
| Net Cash Flow | 0.04 | 0.16 | -0.05 | -0.15 |
| Free Cash Flow | -3.44 | 0.24 | -0.20 | -3.39 |
| CFO/OP | 28% | 91% | -5% | -23% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 73.47 | 97.53 | 128.59 | 111.82 |
| Inventory Days | 168.94 | 552.24 | 249.30 | 186.05 |
| Days Payable | 92.15 | 150.08 | 199.09 | 134.64 |
| Cash Conversion Cycle | 150.26 | 499.68 | 178.80 | 163.22 |
| Working Capital Days | 49.37 | 50.36 | 29.35 | 71.65 |
| ROCE % | 6.19% | -7.38% | 2.69% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Jul 2024 | Aug 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Production Volume - Sugar Based Candies MT ・Standalone data |
|
||||||||||
| Installed Capacity MT ・Standalone data |
|||||||||||
| Estimated Monthly Production from New Agreements Tons ・Standalone data |
|||||||||||
| Projected Annual Revenue from New Manufacturing Agreements INR Crore ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - Newspaper publication of the audited standalone and consolidated financial results for the year ended 31 March 2026.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report for FY ended 31 March 2026 filed with BSE.
-
Voluntary Disclosure Regarding Acknowledgement Of A Long-Standing Business Association
29 May - Company marks 30 years of association with a customer; no new contract or financial impact.
-
Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31 March 2026
29 May - Board approved audited standalone and consolidated FY26 results on 29 May 2026; auditors issued unmodified opinion.
-
Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Statements For The Quarter And Year Ended 31 March 2026.
26 May - Board meeting on 29 May 2026 to approve audited Q4 and FY2026 results.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview[1]
The Company is engaged in the manufacturing, processing, and production of a diverse range of food, beverage, healthcare, and personal care products, including soft drinks, confectioneries, cosmetics, and therapeutic items. It also operates as a distributor, stockist, and liaison for these products in domestic and international markets. Additionally, the Company undertakes turnkey projects, acquires technical know-how, and manufactures machinery and equipment to support its operations and industry collaborations.